GB1034186A - Process for isolating ª‡-antitrypsin from human or animal body fluids - Google Patents

Process for isolating ª‡-antitrypsin from human or animal body fluids

Info

Publication number
GB1034186A
GB1034186A GB8567/63A GB856763A GB1034186A GB 1034186 A GB1034186 A GB 1034186A GB 8567/63 A GB8567/63 A GB 8567/63A GB 856763 A GB856763 A GB 856763A GB 1034186 A GB1034186 A GB 1034186A
Authority
GB
United Kingdom
Prior art keywords
antitrypsin
precipitated
acridine
methyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8567/63A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of GB1034186A publication Critical patent/GB1034186A/en
Priority claimed from AT998668A external-priority patent/AT291693B/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L9/00—Rigid pipes
    • F16L9/02—Rigid pipes of metal
    • F16L9/04—Reinforced pipes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mechanical Engineering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
GB8567/63A 1962-03-03 1963-03-04 Process for isolating ª‡-antitrypsin from human or animal body fluids Expired GB1034186A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEB66202A DE1167484B (de) 1962-03-03 1962-03-03 Verfahren zur Isolierung des ª‡-Antitrypsins aus menschlichen oder tierischen Koerperfluessigkeiten
AT998668A AT291693B (de) 1968-10-14 1968-10-14 Druckrohr mit Außenverstärkung für Wasserkraftanlagen od.dgl.

Publications (1)

Publication Number Publication Date
GB1034186A true GB1034186A (en) 1966-06-29

Family

ID=25605854

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8567/63A Expired GB1034186A (en) 1962-03-03 1963-03-04 Process for isolating ª‡-antitrypsin from human or animal body fluids

Country Status (9)

Country Link
US (1) US3301842A (forum.php)
BE (1) BE629149A (forum.php)
CH (2) CH476028A (forum.php)
CS (1) CS161729B2 (forum.php)
DE (2) DE1167484B (forum.php)
FR (1) FR2020598A1 (forum.php)
GB (1) GB1034186A (forum.php)
NL (1) NL289662A (forum.php)
SE (1) SE309565B (forum.php)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0067293A3 (en) * 1981-05-01 1984-01-04 Medical Res Inst San Francisco Method for isolating alpha-1-antitrypsin

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946105A (en) * 1969-12-18 1976-03-23 Kowa Company, Ltd. Preparation of anti-α1-fetoglobulin
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
EP2520583A1 (en) 2007-08-17 2012-11-07 CSL Behring GmbH Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i
ES2977655T3 (es) 2018-05-17 2024-08-28 Csl Behring Ag Método y sistema de extracción de proteínas
EP4061826A1 (en) 2019-11-20 2022-09-28 CSL Behring AG Method for extracting a protein from a precipitate and method for precipitating impurities
IL310068A (en) 2021-07-29 2024-03-01 Csl Behring Ag Immunoglobulin G purification method and its uses
WO2023052627A1 (en) 2021-10-01 2023-04-06 Csl Behring Ag Improved purification process
IL316094A (en) 2022-04-08 2024-12-01 Csl Behring Ag Methods for disinfecting and/or renewing chromatographic medium
CH719843B1 (de) 2022-06-28 2024-06-14 Csl Behring Ag Verfahren zur Bestimmung der Konzentration eines Analyten in einer Probe, die aus der Resuspendierung von Cohn-Fraktion V oder Kistler/Nitschmann-Präzipitat C erhalten wurde.
WO2024200757A1 (en) 2023-03-29 2024-10-03 Csl Behring Ag Methods of identifying immunoglobulin associated with adverse reactions
WO2025008781A1 (en) 2023-07-04 2025-01-09 Csl Behring Ag Method of purification
WO2025051772A1 (en) 2023-09-04 2025-03-13 Csl Behring Gmbh Spectroscopy methods
WO2025126144A1 (en) 2023-12-13 2025-06-19 Csl Behring Ag Methods of monitoring parameters in solution

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0067293A3 (en) * 1981-05-01 1984-01-04 Medical Res Inst San Francisco Method for isolating alpha-1-antitrypsin

Also Published As

Publication number Publication date
SE309565B (forum.php) 1969-03-31
US3301842A (en) 1967-01-31
DE1167484B (de) 1964-04-09
DE1934689A1 (forum.php) 1970-04-30
BE629149A (forum.php)
CH476028A (de) 1969-07-31
CS161729B2 (forum.php) 1975-06-10
NL289662A (forum.php)
FR2020598A1 (forum.php) 1970-07-17
CH489738A (de) 1970-04-30

Similar Documents

Publication Publication Date Title
GB1034186A (en) Process for isolating ª‡-antitrypsin from human or animal body fluids
Skeggs Jr et al. The preparation and function of the hypertensin-converting enzyme
GB1441751A (en) Purification of albumin by thermocoagulation
DE2548636A1 (de) Antiseren und antikoerper mit spezifischer wirkung gegen krebszellenproteine, verfahren zu ihrer herstellung und arzneipraeparate
Burke The purification of interferon
CA1134352A (en) Ubiquitary tissue protein pp.sub.8
GB1495159A (en) Process reducing the anticomplementary activity of gamma globulins
Beeby et al. The action of rennin on casein The disruption of the k-casein complex
EP0002318A1 (en) Interferon product, process for its preparation and pharmaceutical preparations
SU1713591A1 (ru) Способ получени человеческого лейкоцитарного интерферона
Horisberger et al. An interferon-induced mouse protein involved in the mechanism of resistance to influenza viruses. Its purification to homogeneity and characterization by polyclonal antibodies.
US3515643A (en) Process for the production of lysozyme
Tupper et al. Some observations on the zinc in carbonic anhydrase
Fantes Interferons: purification and physicochemical aspects
Russell et al. Isolation and properties of OSCP and an F1-ATPase binding protein from rat liver mitochondria—Evidence against OSCP as the linking “stalk” between F1 and the membrane
Carlson et al. Crystallization of glycerol 3-phosphate dehydrogenase, triosephosphate dehydrogenase, arginine kinase, and cytochrome c from a single extract of honeybees
GB1034187A (en) Process for isolating ª‡-antitrypsin from human or animal body fluids
US3901870A (en) Derivative of alpha' 1'-fetospecific serum protein and process for its manufacture
Edman et al. Preparation and some properties of hypertensin (angiotonin)
US3624251A (en) Orgotein purification process by heating above 65{20 {0 c.
GB1076776A (en) Process for the extraction of elastase
US3549610A (en) Method of collecting protein substances having biological activity with respect to the nervous system comprising extraction of protein from submaxillary glands with ammonium sulfate or sodium sulfate
SE8600987D0 (sv) Forfarande for framstellning av ett protein- koncentrat ur helblod
US2368464A (en) Process of refining antitoxins
Fowell et al. The fractionation by alcohol of equine antitoxic plasma